Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.88 HKD | +0.51% | +0.10% | -2.79% |
Apr. 16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
Apr. 10 | Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.79% | 7.88B | |
+13.36% | 68.18B | |
+7.33% | 25.78B | |
+6.34% | 7.99B | |
-24.02% | 7.62B | |
+21.83% | 4.45B | |
-2.28% | 3.89B | |
-3.51% | 3.82B | |
+25.02% | 3.69B | |
+3.28% | 3.24B |
- Stock Market
- Equities
- 1099 Stock
- News Sinopharm Group Co. Ltd.
- Sinopharm : Nixes Plan to Take China TCM Private